346 related articles for article (PubMed ID: 20451605)
21. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
22. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
23. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines.
Wang Y; Yu L; Han L; Sha X; Fang X
Int J Pharm; 2007 Jun; 337(1-2):63-73. PubMed ID: 17289311
[TBL] [Abstract][Full Text] [Related]
24. Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously.
Li X; Li P; Zhang Y; Zhou Y; Chen X; Huang Y; Liu Y
Pharm Res; 2010 Aug; 27(8):1498-511. PubMed ID: 20411408
[TBL] [Abstract][Full Text] [Related]
25. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
Huang G; Zang B; Wang X; Liu G; Zhao J
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):981-7. PubMed ID: 26525950
[TBL] [Abstract][Full Text] [Related]
26. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid coated Pluronic F127/Pluronic P123 mixed micelle for targeted delivery of Paclitaxel and Curcumin.
Anirudhan TS; Varghese S; Manjusha V
Int J Biol Macromol; 2021 Dec; 192():950-957. PubMed ID: 34662655
[TBL] [Abstract][Full Text] [Related]
28. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies.
Wang X; Chen Q; Zhang X; Ren X; Zhang X; Meng L; Liang H; Sha X; Fang X
Int J Nanomedicine; 2018; 13():4641-4659. PubMed ID: 30147314
[TBL] [Abstract][Full Text] [Related]
30. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
31. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
32. Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles.
Hou J; Sun E; Zhang ZH; Wang J; Yang L; Cui L; Ke ZC; Tan XB; Jia XB; Lv H
Drug Deliv; 2017 Nov; 24(1):261-269. PubMed ID: 28165804
[TBL] [Abstract][Full Text] [Related]
33. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
34. In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan.
Liang N; Sun S; Hong J; Tian J; Fang L; Cui F
Drug Deliv; 2016 Oct; 23(8):2651-2660. PubMed ID: 26165423
[TBL] [Abstract][Full Text] [Related]
35. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.
Liang H; Yang Q; Deng L; Lu J; Chen J
Drug Dev Ind Pharm; 2011 May; 37(5):597-605. PubMed ID: 21469948
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micelles.
Wang Y; Li Y; Zhang L; Fang X
Arch Pharm Res; 2008 Apr; 31(4):530-8. PubMed ID: 18449513
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P105/poly(caprolactone) copolymers.
Wang Y; Li Y; Wang Q; Fang X
Pharmazie; 2008 Jun; 63(6):446-52. PubMed ID: 18604988
[TBL] [Abstract][Full Text] [Related]
38. Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles.
Li Y; Bi Y; Xi Y; Li L
J Drug Target; 2013 Feb; 21(2):188-99. PubMed ID: 23126604
[TBL] [Abstract][Full Text] [Related]
39. Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.
Russo A; Pellosi DS; Pagliara V; Milone MR; Pucci B; Caetano W; Hioka N; Budillon A; Ungaro F; Russo G; Quaglia F
Int J Pharm; 2016 Sep; 511(1):127-139. PubMed ID: 27374195
[TBL] [Abstract][Full Text] [Related]
40. Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation.
Dahmani FZ; Yang H; Zhou J; Yao J; Zhang T; Zhang Q
Eur J Pharm Sci; 2012 Aug; 47(1):179-89. PubMed ID: 22683386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
